 Pfizer Anacor atopic dermatitis Allergan crisaborole $5.2 eczema drugs share $99 cash firms stock inflammation United States Sandoz Enbrel Reuters price value conversion convertible notes statement M&A strategy taxes Dublin decision spinning off generic medicines valuations biotech drug maker Medivation Inc acquisition non-steroidal topical gel U.S. Food and Drug Administration $2 molecules skin disorder dermatology toenail fungus primary care pediatric termination fee immunology Xeljanz target auto-immune diseases North America patent protection Europe Amgen Inc Centerview Partners Guggenheim Securities Citi Lipton Davis Polk & Wardwell